1-10 of 10
Nicholas Voss
Close
Sort by
Journal Articles

Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials

Joseph M. Connors, MD, Randy D. Gascoyne, MD, Paul Hoskins, MD, James Morris, MD, Tom Pickles, MD, FRCPC, Laurie Sehn, MD, MPH, Tamara Shenkier, MD, Richard Klasa, MD, CM, FRCP(C), Nicholas Voss, MD, Kerry Joanne Savage, MD, BSc, MSc
Journal: Blood
Blood (2010) 116 (21): 417.
https://doi.org/10.1182/blood.V116.21.417.417
Published: 2010
Journal Articles

Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 4459.
https://doi.org/10.1182/blood.V112.11.4459.4459
Published: 2008
Journal Articles

Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

Cynthia L. Toze, MD, FRCP(C), Rauvynne N Sangara, Joseph M. Connors, MD, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Julye Lavoie, MD, Michael J Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Nicholas Voss, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, Donna L Forrest, Kevin W Song, Yasser Abou Mourad, Maryse M Power, Sujaatha Narayanan, Ryan Brinkman, PhD, Clayton Smith, MD, FRCPC
Journal: Blood
Blood (2008) 112 (11): 3305.
https://doi.org/10.1182/blood.V112.11.3305.3305
Published: 2008
Journal Articles

Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT.

Khaled M Ramadan, MB, Kevin W. Song, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 2173.
https://doi.org/10.1182/blood.V112.11.2173.2173
Published: 2008
Journal Articles

Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, MD, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 975.
https://doi.org/10.1182/blood.V112.11.975.975
Published: 2008
Journal Articles

FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.

Kerry J. Savage, MD, MSc, Joseph M. Connors, MD, Don Wilson, MD, Richard Klasa, MD, Tamara Shenkier, MD, Paul Hoskins, MD, Nicholas Voss, MD, Laurie H. Sehn, MD
Journal: Blood
Blood (2007) 110 (11): 213.
https://doi.org/10.1182/blood.V110.11.213.213
Published: 2007
Journal Articles

Allogeneic Stem Cell Transplantation as Treatment for Relapsed and High-Risk Peripheral T-Cell Lymphoma.

Hilary M. O’Leary, Kerry J. Savage, Cynthia L. Toze, Joseph M. Connors, Randy D. Gascoyne, Yasser Abou Mourad, Michael J. Barnett, Donna L. Forrest, Donna E. Hogge, Julye Lavoie, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Clayton Smith, Heather J. Sutherland, Nicholas Voss, Ryan Brinkmann, Kevin Song
Journal: Blood
Blood (2007) 110 (11): 3040.
https://doi.org/10.1182/blood.V110.11.3040.3040
Published: 2007
Journal Articles

Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.

Laurie H. Sehn, MD, MPH, Kerry J. Savage, MD, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Nicholas Voss, MD, Don Wilson, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2007) 110 (11): 787.
https://doi.org/10.1182/blood.V110.11.787.787
Published: 2007
Journal Articles

Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.

Kerry J. Savage, MD, Mukesh Chhanabhai, MD, Nicholas Voss, MD, Shenkier Tamara, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2005) 106 (11): 2817.
https://doi.org/10.1182/blood.V106.11.2817.2817
Published: 2005
Journal Articles

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).

Richard T. Doocey, MBChB, Kevin W. Song, MD, Cynthia L. Toze, MD, Joseph M. Connors, MD, Thomas J. Nevill, MD, Randy D. Gascoyne, MD, Michael J. Barnett, BM, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Nicholas Voss, MD, Clayton A. Smith, MD
Journal: Blood
Blood (2004) 104 (11): 3325.
https://doi.org/10.1182/blood.V104.11.3325.3325
Published: 2004